Thrombolysis of acute arterial occlusion with rt-PA

M. Kurtoǧlu, V. Granit, A. Necefli, M. Kurtoǧlu, R. Güloǧlu

Research output: Contribution to journalArticle

Abstract

The use of thrombolytic agents to treat peripheral arterial occlusions is a new method. Despite its advantages, information about complications caused by the use of rt-PA and about its place in treatment is still incomplete. The aim of this study was to establish a dose range for rt-PA and to follow the patients with a protocol during and after thrombolysis. Between May 1999 to January 2000, 14 patients with symptoms of peripheral arterial occlusion came to Istanbul Medical Faculty Emergency Surgery Unit. The duration of ischaemia before their hospitalization took an average of 44 hours. (Range 3 hours-7 days). A pulse-spray catheter was directed to the thrombus under angiographic control. Bolus injection of 5 mg of rt-PA was followed by 15 minutes of interval. The extent of thrombolysis was checked by angiography and then bolus injection of 5 mg of rt-PA was repeated. After angiographic control, patients having insufficient thrombolysis, received 0.05 mg/kg/hour of infusion for 12 hours. At the end of 12 hours, thrombolytic treatment ended with a control angiography. A thromboembolectomy operation was made to patients still having an occlusion after thrombolysis. To avoid re-occlusion, all of the patients received 1.5 mg/kg/day low molecular weight heparin (enoxaparin) for 1 week. At the end of thrombolysis, 9 patients had complete lysis. A patient, having an occlusion in superior mesenteric artery had 60% recanalisation. 2 patients (14%) having 90% stenosis, needed a balloon angioplasty besides thrombolysis, and both of them had complete reperfusion. 2 patients (14%) needed a thromboembolectomy operation due to insufficient thrombolysis. 2 patients (14%) had a minor bleeding after thrombolytic treatment. After thrombolysis, 2 patients (14%) had a stroke. There were no amputations. 1 of the patients having a stroke, died 2 days after thrombolytic treatment 1 patient died due to myocardial infarction during thrombolysis. 1 patient (7%) died due to diabetic coma on the 20th day. Acute myocardial infarction was the cause of death in 1 patient on the 25th day. In conclusion pulse spray thrombolysis with rt-PA is safe and efficient. Moreover there is a reduction in complications and need for surgical procedure. The recent problem is to find the optimum dosages for the best thrombolysis and for least complications.

Original languageEnglish (US)
Pages (from-to)165-172
Number of pages8
JournalTurkish Journal of Haematology
Volume18
Issue number3
StatePublished - Jan 1 2001

Keywords

  • Acute arterial occlusion
  • Pulse spray catheter
  • Thrombolysis
  • rt-PA

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Thrombolysis of acute arterial occlusion with rt-PA'. Together they form a unique fingerprint.

  • Cite this

    Kurtoǧlu, M., Granit, V., Necefli, A., Kurtoǧlu, M., & Güloǧlu, R. (2001). Thrombolysis of acute arterial occlusion with rt-PA. Turkish Journal of Haematology, 18(3), 165-172.